Ibrutinib and PD-1 Blockade in High Risk Lymphocytic Leukemia
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
National Institutes of Health Clinical Center (CC)
Roswell Park Cancer Institute
Acerta Pharma BV
Mayo Clinic
OHSU Knight Cancer Institute
Mayo Clinic